The expenses associated with managing hypertension, hyperlipidemia, diabetes, and their cardiovascular complications far exceed the costs of effective weight loss intervention
Semaglutide mimics glucagon-like peptide 1 (GLP-1), whereas cagrilintide mimics the satiety hormone amylin, so each curbs appetite through a distinct pathway
This also leads to increased GH production but through a different pathway than Sermorelin
However, we are cautious of potential side effects such as fluid overload, and always aim to provide a balanced treatment
And that's why I'm here, because it just flows right out of me
Each compound has its own Phase 2 and Phase 3 dataset